About Us

Fa'amatalaga a le Kamupani

Innovita Biological Technology Co., Ltd. (faʻatasi ma ona lala, faʻaigoaina faʻatasi o le "INNOVITA",) o se kamupani biotechnology o loʻo taulaʻi i suʻesuʻega, atinaʻe, gaosiga ma faʻatau atu o oloa in vitro diagnostic POCT. E aofia ai Innovita (Tangshan) , Innovita (Beijing) ma Innovita (Guangzhou).

● Faavaeina i le 2006

● Faʻatūina nofoaga autu R&D i Beijing ma Guangzhou, ma faʻavae gaosiga i Qian'an, Hebei

Fa'amatalaga a le Kamupani

Faavaeina i le 2006, ua fausia e le INNOVITA ni tulaga faʻapitoa e ono e pei o le antigen & antibody preparation, virus culture, colloidal gold, ELISA, fluorescence chromatography, immunofluorescence, ma faʻatautaia le National High-tech R&D Programme i le matata o suʻesuʻega faʻamaʻi faʻamaʻi tele a le atunuʻu ma le tele. isi galuega fa'alesoifua maloloina lautele.E le gata i lea, o INNOVITA e silia ma le sefulu pateni fou a le atunuʻu ma faʻatūina Beijing R & D nofoaga autu, Guangzhou R & D nofoaga autu, Hebei gaosiga faavae.Faatasi ai ma faleaoga mama tetele, ma le faatuina colloidal auro, ELISA, fluorescence chromatography, PCR, immunofluorescence laina gaosiga, INNOVITA ua maua CE ma ISO13485 tusi faamaonia.

I le taimi nei, o oloa INNOVITA o loʻo i ai suʻesuʻega o le manava, suʻesuʻega o le fualaʻau, suʻega hepatitis, suʻega TORCH, suʻega cardiovascular, suʻega o le fatu ma isi.O fesoʻotaʻiga faʻatau na ufiufi uma itumalo ma itulagi i Saina, ma salalau atu i Asia i Sautesasae, Sasaʻe Tutotonu, Aferika, Amerika Latina, Europa Europa ma isi itulagi i fafo.INNOVITA pipi'i ile filosofia fa'atau pisinisi fa'atau, ma tautua tagata fa'atau i oloa sa'o ma faigofie.O mana'oga o tagata fa'atau o le tuliloaina lea o INNOVITA.

Atina'e Fa'agasologa

I le 2006

● Faʻavaeina Beijing R&D nofoaga tutotonu.

I le 2011

● Fa'atuina fale gaosi Tangshan.

I le 2014

● ISO 13485 fa'amaonia.

I le 2018

● Fuafuaga fa'apitoa a le Kenese Capital.
● Amata le galulue faʻatasi faʻapitoa faʻavaomalo.

I le 2019

● Fuafuaga fa'apitoa a le Sequoia Capital.

I le 2020

● Muamua na faamaonia e le NMPA COVID-19 IgM/IgG Combo Test.
● auina atu i fafo i le silia ma le 70 atunuu / eria.
● Fa'aui atu i le Advanced Collective i le National Commendation Congress for Combating COVID-19 Pandemic.
● O le su'ega COVID-19 IgM/IgG na maua le Fa'atagaga mo Fa'alavelave Fa'afuase'i (EUA) mai le US FDA.

I le 2022

● Fonotaga muamua fa'alauiloa ile SSE STAR Market, ma o le a lisiina ile China Sci-Tech Innovation Board i se taimi lata mai.

lala

Beijing R&D & Maketi Nofoaga

Fa'avae:2006

Taulai:R&D, gaosiga, maketiina o oloa in-vitro diagnostic, e aofia ai tulaga e pei ole immunodiagnosis, molecular diagnostics, ma gene chips.

Qian'an Manufacturing & Logistic Center

Fa'avae:2011

Fale:Ufiufi se eria o le 150 eka, e tusa ma le 8,000 ㎡ nofoaga o aʻoaʻoga, faʻapipiʻiina i le tele o laina gaosiga o auro colloidal, ELISA, PCR.

Fa'ailoga:ISO 13485, CE, FDA, NMPA, ma isi.

Guangzhou R&D Nofoaga Autu

Fa'avae:2020

Taulai:R&D o tekinolosi IVD

Fa'avae

Feso'ota'iga Maketi

I le maeʻa ai o tausaga o atinaʻe, ua maeʻa ona maua e Innovita se faʻatauga atoa ma fesoʻotaʻiga auaunaga, faʻatasi ai ma auala faʻatau e aofia ai le 32 itumalo ma itulagi i Saina, ma faʻatau atu i maketi o le lalolagi e pei o Southeast Asia, Middle East, Aferika, Latina Amerika, Europa, ma isi.

Su'ega a le Innovita 2019-nCoV Ab o lo'o fa'aalia i luga ole tulaga fa'alavelave fa'afuase'i a le atunu'u mo vaila'au ma masini fa'afoma'i

I le aso 28 o Fepuari, 2020, na asiasia ai e le Palemia Li Keqiang le tulaga faʻalavelave faʻafuaseʻi a le atunuʻu mo vailaʻau ma masini faʻafomaʻi o le COVID-19.O le su'ega a le Innovita 2019-nCoV Ab na fa'aalia o le su'ega muamua a le NMPA o le IgM/IgG combo antibody su'ega, lea na lipotia i le CCTV.

Su'ega a le Innovita 2019-nCoV Ab na faaigoaina e le Academician Zhong Nanshan

● I le aoauli o Fepuari 23, 2020, na faailoa mai ai e le Academician Zhong Nanshan i se faatalanoaga mamao i Guangzhou ma le vaega faafomai a Guangdong o loo faanatinati atu e fesoasoani ia Jingzhou e faapea ua faamaonia e le National Medical Products Administration ni pusa suʻesuʻe fou se lua mo le 2019-nCoV, o se tasi o ia mea gaosia e Innovita (Tangshan) Biological Technology Co., Ltd.

● E faʻaaogaina e le pusa le auala auro colloidal, lea e mafai ona iloa ai le antibody lgM i le tino o le tagata maʻi.E mafai ona iloa le antibody lgM i le aso lona 7 o le ma'i po'o le aso lona 3 o le amataga, lea e fesoasoani tele mo le su'esu'eina atili o le ma'i.Fai mai Zhong Nanshan: "E mafai ona vave iloa tagata mamaʻi mo se suʻesuʻega lelei. E mafai ona fesoasoani ia i tatou e vave vavaeeseina tagata masani mai i latou ua aʻafia."